Assessment of prognostic value and development of predictive model for prolonged lymphopenia in patients with glioblastoma following chemoradiotherapy
Journal of Radiation Research · 23.09.2025 · 66 (5) · 542-550
DOI: 10.1093/jrr/rraf045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Radiation Research, online erschienen am 11.08.2025. Verfasst von Shuhei Takahashi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638, Japan. Hauptthemen laut MEDLINE: Glioblastoma, Lymphopenia, Chemoradiotherapy, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science KAKENHI.
Abstract (Originalsprache)
Lymphopenia during chemoradiotherapy (CRT) for glioblastoma has been shown to be a poor prognostic factor. However, the relationship between prolonged lymphopenia (PL) after CRT and prognosis remains unclear. This study aimed to explore the relationship between PL and glioblastoma prognosis and develop a predictive model for PL risk. We analyzed 87 patients with primary glioblastoma who underwent postoperative CRT with 60 Gy in 30 fractions of radiotherapy and temozolomide. PL was defined as grade 2 or higher lymphopenia 1 month after the completion of CRT. We conducted survival analysis, identified risk factors for PL, and developed a predictive model for PL risk. Of the 87 patients, 41 developed PL, and progression-free survival (PFS) was significantly shorter in the PL group (median 8.0 months vs 15.4 months, P = 0.003). However, there was no significant difference in overall survival between the two groups. PL was also a significant factor for shorter PFS in multivariable analysis (P = 0.040). Brain V20Gy (percentage of brain volume receiving ≥20 Gy), gross total resection (GTR), and preoperative Karnofsky performance status (KPS) were identified as significant risk factors for PL. The predictive model showed that the risk of PL could be predicted by brain V20Gy, sex, age, GTR and preoperative KPS. PL was identified as a PFS shortening factor. Our model suggests that reducing irradiated brain volume may help prevent PL and could potentially improve glioblastoma prognosis by preserving cancer immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638, Japan.
- Department of Radiation Oncology, Hokkaido University Hospital, Kita 14, Nishi 6, Kita-ku, Sapporo 060-8648, Japan.
- Global Center for Biomedical Science and Engineering, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638, Japan.
- Department of Neurosurgery, Faculty of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638, Japan.
- Data Science Center, Promotion Unit, Institute of Health Science Innovation for Medical Care, Hokkaido University Hospital, Kita 14, Nishi 6, Kita-ku, Sapporo 060-8648, Japan.
- Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638, Japan.
ORCID-Profile: Shuhei Takahashi, Kentaro Nishioka, Takashi Mori, Keiji Kobashi, Yoichi M Ito, Shinya Tanaka
Förderung
- Japan Society for the Promotion of Science KAKENHI
Zitieren
APA
Takahashi, S., Nishioka, K., Mori, T., Yamaguchi, S., Ishi, Y., Kobashi, K., Ito, Y. M., Tanei, Z. I., Kanno-Okada, H., Tanaka, S., & Aoyama, H. (2025). Assessment of prognostic value and development of predictive model for prolonged lymphopenia in patients with glioblastoma following chemoradiotherapy. Journal of Radiation Research, 66(5), 542-550. https://doi.org/10.1093/jrr/rraf045
Vancouver
Takahashi S, Nishioka K, Mori T, Yamaguchi S, Ishi Y, Kobashi K, et al. Assessment of prognostic value and development of predictive model for prolonged lymphopenia in patients with glioblastoma following chemoradiotherapy. Journal of Radiation Research. 2025;66(5):542-550. doi:10.1093/jrr/rraf045
BibTeX
@article{Takahashi2025,
author = {Takahashi, Shuhei and Nishioka, Kentaro and Mori, Takashi and Yamaguchi, Shigeru and Ishi, Yukitomo and Kobashi, Keiji and Ito, Yoichi M and Tanei, Zen-Ichi and Kanno-Okada, Hiromi and Tanaka, Shinya and Aoyama, Hidefumi},
title = {Assessment of prognostic value and development of predictive model for prolonged lymphopenia in patients with glioblastoma following chemoradiotherapy},
journal = {Journal of Radiation Research},
year = {2025},
volume = {66},
number = {5},
pages = {542--550},
doi = {10.1093/jrr/rraf045}
}
EUVIMED